Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Study of Pomalidomide, Cyclophosphamide, and Dexamethasone in Relapsed Refractory Myeloma: Safety Profile in Mexican Population

NCT03601624 is registered in ClinicalTrials.gov with Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado as lead sponsor.

NCT NCT03601624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03601624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Study of Pomalidomide, Cyclophosphamide, and Dexamethasone in Relapsed Refractory Myeloma: Safety Profile in Mexican Population
Lead sponsor
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado
Phase
Phase 2
Overall status
Unknown status
Start date
September 1, 2018
Completion date
July 30, 2020
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma in relapse, multiple myeloma progression, refractory multiple myeloma